| http://dbpedia.org/ontology/abstract
|
Delix Therapeutics is an American biotech … Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft.d in 2019 by David E. Olson and Nick Haft.
|
| http://dbpedia.org/ontology/foundingYear
|
2019
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.delixtherapeutics.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
68574851
|
| http://dbpedia.org/ontology/wikiPageLength
|
6128
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1115729961
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Neuroplasticity +
, http://dbpedia.org/resource/Psychedelic_drug +
, http://dbpedia.org/resource/Stimulant +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_Boston +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/5-MeO-DMT +
, http://dbpedia.org/resource/Ketamine +
, http://dbpedia.org/resource/Category:2019_establishments_in_Massachusetts +
, http://dbpedia.org/resource/Psychoplastogen +
, http://dbpedia.org/resource/Tabernanthalog +
, http://dbpedia.org/resource/Series_A_round +
, http://dbpedia.org/resource/Ibogaine +
, http://dbpedia.org/resource/Category:American_companies_established_in_2019 +
, http://dbpedia.org/resource/David_E._Olson +
, http://dbpedia.org/resource/Depression_%28mood%29 +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/AAZ-A-154 +
, http://dbpedia.org/resource/Psilocybin +
, http://dbpedia.org/resource/Post-traumatic_stress_disorder +
, http://dbpedia.org/resource/Cardiotoxicity +
, http://dbpedia.org/resource/University_of_California%2C_Davis +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_the_21st_century +
, http://dbpedia.org/resource/Central_nervous_system_disease +
, http://dbpedia.org/resource/DSM-5 +
, http://dbpedia.org/resource/National_Institute_on_Drug_Abuse +
|
| http://dbpedia.org/property/founded
|
2019
|
| http://dbpedia.org/property/hqLocation
|
Boston, Massachusetts
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Mark Rus
|
| http://dbpedia.org/property/name
|
Delix Therapeutics, Inc.
|
| http://dbpedia.org/property/type
|
Private
|
| http://dbpedia.org/property/website
|
https://www.delixtherapeutics.com +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Small +
, http://dbpedia.org/resource/Template:Infobox_company +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:American_companies_established_in_2019 +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_the_21st_century +
, http://dbpedia.org/resource/Category:Companies_based_in_Boston +
, http://dbpedia.org/resource/Category:2019_establishments_in_Massachusetts +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Delix_Therapeutics?oldid=1115729961&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.delixtherapeutics.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Delix_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
Delix Therapeutics, Inc. ("Delix")
|
| owl:sameAs |
http://dbpedia.org/resource/Delix_Therapeutics +
, http://www.wikidata.org/entity/Q113002950 +
, https://global.dbpedia.org/id/GW5qy +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
Delix Therapeutics is an American biotech … Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft.d in 2019 by David E. Olson and Nick Haft.
|
| rdfs:label |
Delix Therapeutics
|
